Who Owns PROCEPT BioRobotics Stock?
NASDAQ: PRCTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 100.50%
- Institutions (% of float)
- 104.13%
- Held by insiders
- 3.49%
- Institutional holders
- 363
- Institutions 96.5%
- Insiders 3.5%
- Public and other 0.0%
Who owns PROCEPT BioRobotics stock?
Institutional investors own about 100.5% of PROCEPT BioRobotics's shares, spread across 363 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.49% of PRCT.
The largest institutional holders are Blackrock Inc. (8.50%), T. Rowe Price Investment Management, Inc. (5.70%) and BNP Paribas Asset Management Holding S.A. (4.93%). Together, the top 10 institutions control 41.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their PRCT positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PRCT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 4.87M | 8.50% | +11.6% |
| T. Rowe Price Investment Management, Inc. | 3.27M | 5.70% | -0.3% |
| BNP Paribas Asset Management Holding S.A. | 2.82M | 4.93% | -8.6% |
| Vanguard Portfolio Management LLC | 2.53M | 4.41% | +4.3% |
| Vanguard Capital Management LLC | 2.46M | 4.30% | +2.6% |
| Chicago Capital, LLC | 2.07M | 3.62% | -4.0% |
| State Street Corporation | 1.62M | 2.82% | +5.7% |
| Geode Capital Management, LLC | 1.48M | 2.59% | +8.8% |
| FMR, LLC | 1.44M | 2.52% | -1.2% |
| Price (T.Rowe) Associates Inc | 1.33M | 2.33% | +119.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PRCT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.71M | 2.98% |
| iShares Trust-iShares Russell 2000 ETF | 1.44M | 2.51% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1.32M | 2.30% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.24M | 2.16% |
| JANUS INVESTMENT FUND-Janus Henderson Venture Fund | 890.51K | 1.55% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 711.30K | 1.24% |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 695.94K | 1.22% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 652.02K | 1.14% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 647.17K | 1.13% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust | 620.72K | 1.08% |
Frequently asked questions
Who is the largest shareholder of PROCEPT BioRobotics?
Blackrock Inc. is the largest institutional shareholder of PRCT, owning 8.50% of shares outstanding (4.87M shares) as of its latest 13F filing.
What percentage of PROCEPT BioRobotics is owned by institutions?
Institutions own about 100.5% of PRCT shares and 104.1% of the public float.
How much of PROCEPT BioRobotics do insiders own?
Insiders, such as officers and directors, own about 3.49% of PRCT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.